Elevance Health, Inc. (ELV) Stock

About Elevance Health, Inc.

Elevance Health, Inc. is led by CEO Gail Koziara Boudreaux, employs 104,200 people, headquartered in Indianapolis, US, publicly traded since 2001.

Elevance Health, Inc. (ELV) stock trades at $439.95 with a market capitalization of $95.41B. The stock is valued at a price-to-earnings (P/E) ratio of 17.60, price-to-book of 1.92, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $274.84 and $448.97, and currently trades 2.0% below its 52-week high. It pays a dividend yielding 1.74%.

On profitability, Elevance Health, Inc. generates a return on equity (ROE) of 11.24%, return on capital employed of 7.54%, an operating margin of 4.07%, a net profit margin of 2.47%.

In its most recent fiscal year, Elevance Health, Inc. reported annual revenue of $199.1B, net profit of $5.7B. Over the last 5 fiscal years, revenue grew at an average annual rate of 10.3%, and net profit grew at an average annual rate of 4.4%.

The balance sheet shows a debt-to-equity ratio of 0.69, a current ratio of 1.24, total assets of $121.5B, $9.5B in cash and equivalents.

ELV has an average daily trading volume of 1,321,437 shares, a beta of 0.70 (historically less volatile than the overall market).

Elevance Health, Inc. by the numbers, 2016–2025

Between 2016 and 2025 Elevance Health, Inc. reported revenue of $85.0B rising to $199.1B, a change of +134.3% across 10 years. Compounded, revenue has grown 10.3% a year over five years, 8.3% over three, 12.6% over the last twelve months. Net profit rose to $5.7B.

Operating margin went from 6.4% in 2016 to 4.1% in 2025, a fall of 2.3 percentage points. The most recent net margin is 2.47%. On a trailing twelve-month basis to Jun '26, revenue is $201.1B and net profit $5.0B.

Borrowings rose from $15.7B to $33.2B, cash from operations was $4.3B in the latest year, positive in 10 of the last 10.

Return on equity has averaged 15.2% over five years, and was 12.9% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Elevance Health, Inc. (ELV) — frequently asked questions